# Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

> **NCT00501644** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 59 (actual)

## Conditions studied

- Ovarian Cancer
- Fallopian Tube Cancer
- Peritoneal Cancer

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** GM-CSF (Sargramostim)
- **DRUG:** Interferon Gamma

## Key facts

- **NCT ID:** NCT00501644
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2012-08-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501644, "Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00501644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*